Buprenorphine Black Cherry 2 mg Troche recalled over mold contamination

Recall date

March 10, 2020

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

Matthew 7:25 Inc dba Thrive Pharmacy recalls Buprenorphine Black Cherry 2 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, Thrive Pharmacy 2…

Recall number

D-1054-2020

FDA classification

Class II

Brand / firm

Matthew 7:25 Inc dba Thrive Pharmacy

Sold / distributed

Florida

Why it was recalled

Subpotent Drug

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Buprenorphine Black Cherry 2 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, Thrive Pharmacy 2863 St Johns Bluff RD. South # 135 Jacksonville, Florida